(Q35643929)

9 August 2017

1 reference

title

Allergic reactions to Japanese encephalitis vaccine (English)

1 reference

Japanese encephalitis virus

9 August 2017

main subject

0 references

Japanese encephalitis

1 reference

Japanese encephalitis vaccine

inferred from title

1 reference

1 reference

Anne-Marie Plesner

1

1 reference

9 August 2017

publication date

1 November 2003

1 reference

Immunology and Allergy Clinics of North America

9 August 2017

published in

1 reference

9 August 2017

volume

23

1 reference

9 August 2017

issue

4

1 reference

9 August 2017

page(s)

665-697

1 reference

New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998.

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Control of Japanese encephalitis in Japan: immunization of humans and animals, and vector control

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Vaccines for Japanese encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Japanese B encephalitis in Vietnam

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Japanese encephalitis after a 10-day holiday in Bali

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Fatal Japanese encephalitis in a Danish tourist visiting Bali for 12 days

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Movement disorders in Japanese encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

The epidemiology of Japanese encephalitis: prospects for prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Japanese encephalitis vaccines: current vaccines and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Current status of flavivirus vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Japanese encephalitis vaccine in travellers. Is wider use prudent?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Systemic allergic reactions to Japanese encephalitis vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Adverse events after Japanese encephalitis vaccination: review of post-marketing surveillance data from Japan and the United States. The VAERS Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Systemic reactions in U.S. Marine Corps personnel who received Japanese encephalitis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Further experience with Japanese encephalitis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Protection against Japanese encephalitis by inactivated vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Japanese encephalitis vaccine: persistence of antibody up to 3 years after a three-dose primary series

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Immune responses to Japanese encephalitis virus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Immunisation against Japanese Encephalitis in Nepal: Experience of 1152 subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Evaluation of the potency and safety of inactivated Japanese encephalitis vaccine in US inhabitants

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Short-term safety of live attenuated Japanese encephalitis vaccine (SA14-14-2): results of a randomized trial with 26,239 subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infants

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Immunogenicity of live attenuated SA14-14-2 Japanese encephalitis vaccine--a comparison of 1- and 3-month immunization schedules

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Immunogenicity of a Japanese encephalitis DNA vaccine candidate in cynomolgus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Enhancing effect of vaxfectin on the ability of a Japanese encephalitis DNA vaccine to induce neutralizing antibody in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Development of Vero cell-derived inactivated Japanese encephalitis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

A purified inactivated Japanese encephalitis virus vaccine made in Vero cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Epidemic encephalitis in military personnel; isolation of Japanese B virus on Okinawa in 1945, serologic diagnosis, clinical manifestations, epidemiologic aspects and use of mouse brain vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Side-effects with Japanese encephalitis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Adverse reactions to Japanese encephalitis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Immunisation against Japanese encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Allergic mucocutaneous reactions to Japanese encephalitis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Systemic immediate-type reactions to gelatin included in Japanese encephalitis vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Anaphylaxis to Japanese encephalitis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Two patterns of systemic immediate-type reactions to Japanese encephalitis vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Specific IgE and IgG to gelatin in children with systemic cutaneous reactions to Japanese encephalitis vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Adverse reactions to Japanese encephalitis vaccine in travellers

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Australian Case-Control Study of Adverse Reactions to Japanese Encephalitis Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Case-control study of allergic reactions to Japanese encephalitis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Acute disseminated encephalomyelitis after Japanese B encephalitis vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Acute disseminated encephalomyelitis after treatment with Japanese B encephalitis vaccine (Nakayama-Yoken and Beijing strains).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Acute disseminated myelitis after Japanese B encephalitis vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Acute transverse myelitis after Japanese B encephalitis vaccination in a 4-year-old girl

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Neurological complications and Japanese encephalitis vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Neurological complications to vaccination against Japanese encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Acute transverse myelitis in childhood: nine cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

The vaccine data link in Nha Trang, Vietnam: a progress report on the implementation of a database to detect adverse events related to vaccinations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

The reporting sensitivities of two passive surveillance systems for vaccine adverse events

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

The Vaccine Adverse Event Reporting System (VAERS)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

The Brighton Collaboration: enhancing comparability of vaccine safety data

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

Japanese encephalitis vaccine for travelers: exploring the limits of risk.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900102-4

7 January 2021

10.1016/S0889-8561(03)00102-4

Identifiers

DOI

1 reference

9 August 2017

1 reference